Open AccessLong-term outcomes and clinical impact of anti-HLA donor-specific antibodies (DSA) after liver transplantation: prospective study in a pilot cohort.
Author(s) -
Aránzazu CaballeroMarcos,
Raquel Díaz Ruiz,
Mario Romero Cristóbal,
Ainhoa Fernández Yunquera,
F Díaz Fontenla,
L Pérez Carazo,
María Isabel Peligros Gómez,
Jose Luis Vicario Moreno,
Magdalena Salcedo Plaza,
Rafael Bañares
Publication year - 2020
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2020.7337/2020
Subject(s) - medicine , liver transplantation , human leukocyte antigen , prospective cohort study , cohort , donor specific antibodies , antibody , term (time) , transplantation , cohort study , immunology , antigen , physics , quantum mechanics
the presence of donor-specific antibodies (DSA) is thought to affect survival of the allograft and patient after liver transplantation (LT). However, their significance is not well understood.